Companies / BOC Sciences / Rocatinlimab
BOC Sciences

Rocatinlimab | BOC Sciences

Rocatinlimab is an immunoglobulin G1 (IgG1) anti-OX40 monoclonal antibody developed for the treatment of atopic dermatitis, prurigo nodularis and asthma.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.